
CEO Interviews
Generex Biotechnology Corporation (OTCQB:GNBT) CEO Interview
Interview with Mark Fletcher, CEO […]
Interview with Mark Fletcher, CEO […]
(CSE: MRM, OTCQX: MMTIF) […]
[TSX: NB; OTCQX: NIOBF; and FSE: BR3] […]
Presentations Include Long-Term Selected Side Effect Data for Prostate Cancer; FMEA Quality Assessment for Head and Neck Cancer Utilizing Cesium-131; Primary Management of Gynecologic Malignancies With Cesium-131; and Permanent Brain Brachytherapy Treatment Planning Using Stranded Cesium-131 Seeds […]
(TSX: NB, OTCQX: NIOBF, FSE: BR3) […]
(CSE: MRM, OTCQX: MMTIF) […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com